Books > Business & Economics > Industry & industrial studies > Manufacturing industries > Pharmaceutical industries
|
Buy Now
The Politics of the International Pricing of Prescription Drugs (Hardcover, New)
Loot Price: R2,423
Discovery Miles 24 230
|
|
The Politics of the International Pricing of Prescription Drugs (Hardcover, New)
Expected to ship within 10 - 15 working days
|
Harrison analyzes how the U.S. research pharmaceutical industry,
faced with domestic political opposition to the prices it charged
for prescription drugs, chose to pursue its policy goal of greater
appropriability of its intellectual property through the
institutions of foreign economic policymaking. As Harrison
explains, a new body of literature has developed to analyze the
emergence of intellectual property as a major international trade
issue. For many researchers, the inclusion of trade related
intellectual property (TRIPS) into the Uruguay round of the General
Agreement on Tariffs and trade (GATT) negotiations marks an
important demonstration of the political influence of U.S.
knowledge-intensive industries. However, as he demonstrates, a more
thorough specification of the domestic political environment
reveals that the research pharmaceutical industry was incapable of
achieving its domestic policy objectives at the same time that it
is credited with immense international political power. By
providing a theory of institutional choice, Harrison reconciles
this incongruity. He explains the strategic choices of the research
pharmaceutical industry as a function of the transaction costs
associated with pursuing its policy objectives within a variety of
institutional alternatives. He concludes that he
internationalization of intellectual property rights was a result
of the changing domestic political environment in which the
research pharmaceutical industry found itself the loser in a series
of domestic economic policy battles. A thoughtful analysis of
particular important to scholars, researchers, and policy makers
involved with international trade, intellectual property, the
pharmaceutical industry, and public policy.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
You might also like..
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.